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Graphical abstract 
 
 
 
Abstract 
 
This study compared the effects of different sources of laser phototherapy on the cell 
viability of the in vitro human breast cancer cell lines. Laser phototherapy is used in the 
breast cancer clinical treatment, despite the limited safety information of laser irradiation 
effect on the cancer cell behavior. This study contributed on the development of 
guidelines for safer laser usage in treating breast cancer and minimising the possibility of 
activating postmastectomy lymphedema. Cancer cell viability and morphology were 
studied in this research. Human breast cancer (MDA-MB-231) cell lines were cultured for 24 
hours in CO2 incubator and irradiated with different laser sources and number of pulse. The 
viability of cancer cells were assessed by MTT assay 24 hours after laser irradiation. The result 
showed that MDA-MB-231 cell viability increased after being irradiated by excimer 248 nm 
laser. However, the cancer cell viability slightly decreased after irradiation by both Nd:YAG 
1064 and 532 nm. Although certain doses of laser may affect the MDA-MB-231 cell viability, 
additional laser exposures had nearly no effect. The research shows that Nd:YAG 1064 nm 
more effective in lowering cancer cell survivability than 532 nm and 248 nm. Further in vivo 
studies are needed for better understanding on the mechanism of laser-tissue interaction 
and improve the laser usage safety in photothermal therapy.  
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Abstrak 
 
Kajian ini berbanding kesan beberapa sumber fototerapi laser terhadap kemandirian sel in 
vitro sel kanser payudara manusia. Laser fototerapi digunakan dalam rawatan klinikal 
kanser payudara, walaupun maklumat keselamatan yang terhad mengenai kesan sinaran 
laser ke atas tingkah laku sel kanser. Kajian ini mampu menyumbang kepada garis 
panduan yang lebih baik bagi penggunaan laser yang selamat dalam merawat kanser 
payudara dan meminimumkan kemungkinan mengaktifkan postmastectomy 
lymphedema. Tindak laku dan morfologi kanser sel dikaji dalam kajian ini. Sel kanser 
payudara manusia (MDA-MB-231) dikulturkan selama 24 jam dalam inkubator CO2 dan 
disinar dengan laser dan bilangan denyut yang berbeza. Kemandirian sel kanser telah 
dinilai oleh ujian MTT 24 jam selepas sinaran laser. Hasil menunjukkan sel MDA-MB-231 
jumlah sel meningkat selepas radiasi laser excimer 248 nm. Walau bagaimanapun, jumlsh 
sel kanser sedikit menurun selepas sinaran Nd: YAG 1064 dan 532 nm. Walaupun sinaran 
laser tertentu boleh menjejaskan jumlah sel MDA-MB-231, tambahan denyutan laser 
hampir mempunyai tiada kesan. Kajian ini menunjukkan bahawa Nd: YAG 1064nm lebih 
berkesan dalam menurunkan kemandirian sel kanser berbanding 532 nm dan 248 nm. 
Kajian in vivo lanjutan diperlukan untuk pemahaman yang lebih baik mengenai 
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mekanisma interaksi laser-tisu dan meningkatkan keselamatan penggunaan laser dalam 
terapi photothermal. 
 
Kata kunci: Fototerapi laser MDA-MB-231, Excimer, postmastectomy lymphedema 
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1.0  INTRODUCTION 
 
The clinical application of a thermal laser with low 
power outputs [1, 2] has been used now for many 
years in laser phototherapy to treat numbers of 
disease including epidermal abrasions, osteoarthritis 
and recently breast cancer-related lymphedema [3-
5]. Both physical and psychological will get impacts of 
the untreated lymphoedema especially on an 
individual’s well-being. The signs and symptoms of 
lymphoedema are limb deformation and swelling, 
immobilization, restricted shoulder mobility, burning, 
elevated skin temperature, fibrosis, and social isolation 
[3, 6-9]. 30% of patients treated for breast cancer will 
have lymphoedema of the arm as it was one of the 
main side effects following breast cancer radiation 
therapy or surgery [6]. For the present time, there still 
no definite treatment for lymphoedema, although 
standard treatments for lymphedema include 
pressotherapy, exercise, manual lymphatic drainage, 
compression bandaging and skin care. However these 
treatments are generally applied in combination of 
each other known as Complete Decongestive 
Therapy (CDT) and it is very expensive, time 
consuming, require qualified medical professionals, less 
accepted by patients and limited effectiveness [10-
12].  
In previous studies [13-15], double blind and 
medicine-controlled trials have shown the 
effectiveness of Low Level Laser Therapy (LLLT) in 
improving the postmastectomy lymphedema 
symptoms. The treatments consisted of radiation with 
904 nm wavelength, energy density of 1.5 J/cm2, from 
10 to 17 points distributed in the affected area and the 
number of sessions ranged from 8 to 36 . A significant 
reduction in the size of the affected arm, volume of 
extracellular fluids and the tissue hardness, as well as 
improved the shoulder mobility and grip strength [16, 
17].  
Powell et al. [18] used four different cell line, human 
breast adenocarcinoma (MCF-7), human breast 
ductal, carcinoma with melanomic genotypic traits 
(MDA-MB-435S), immortalized human mammary 
epithelial (SVCT and Bre80hTERT), to study the effect of 
three different laser source, 780 nm continuos (50 mW), 
830 nm continuos (30 mW) and 904 nm pulsed (90 mW) 
with range 1 to 3 laser exposure on cells proliferation. 
The result showed, although certain doses of laser will 
increase cell proliferation, however multiple doses 
exposures had either no effect or showed negative 
dose-response relationships. There was no sign of 
malignant modification and transformation of cells by 
laser phototherapy was observed under the applied 
conditions. 
In other research [19], Schartinger et al. used human 
bronchial epithelial cells (BEAS-2B), human gingival 
fibroblasts and oral squamous cell carcinoma cells 
(SCC-25) to determine the cell proliferation after 
irradiate by GaAlAs, diode laser at 660 nm with power 
output 350 mW for 15 min and 3 repetition exposure in 
subsequent days. The result shows, there was 
increasing in cell proliferation for human gingival 
fibroblasts but decreasing for non-neoplastic epithelial 
cells and oral carcinoma cells SCC-25. However in 
SCC-25 cells, there is a proapoptotic effect of laser 
phototherapy was observed. 
Gao et al., [20] studied the effect of two low power 
laser irradiation (LPLI) of  He–Ne laser, 632.8 nm and 5 
mw at fluence of 0.8 J/cm2 and high fluence LPLI of 
He–Ne laser, 632.8 nm and 40 mw at fluence of 60 
J/cm2 on ASTC-a-1 cells. The study showed low fluence 
of LPLI will increase the cell proliferation and activated 
the protein kinase Cs (PKCs) in the cells. However, the 
study reported that high fluence of LPLI was decrease 
the cell viability and PKCs activity but increases the 
cell apoptosis.  
These finding encourage more research on the 
application of laser phototherapy in cancer treatment 
such as chemotherapy and radiotherapy induced 
BCRL and oral mucositis. Few safety studies on the 
usage of laser in cancer treatment have been 
undertaken, although it has been by numbers of 
researches suggested that laser phototherapy has no 
effect on disease recurrence or survival in cancer 
patients [21,22] and it been suggested by Werneck et al. 
[23] ‘‘clinically, irradiating a cancer lesion may result in 
increased tumor progression’’. Although researches 
suggests that the growth of cancer cell in culture can 
be stimulated by laser phototherapy, and the clinical 
application laser in cancer treatment is increasing. The 
effect on cancer cells in vivo requires more critical 
review on the safety and efficiency of the laser 
application.  
In seeking to identify the effective and safe dose 
parameters for the treatment of cancer, the aims of 
this research were to study the response of  human 
breast cancer cell lines MDA-MB-231 in vitro with 
commonly used laser phototherapy at wavelengths of 
248 nm, 532 nm, and 1064 nm and varied the number 
of doses exposure. This finding would lead to 
determination the relationship of wavelength-
response, energy-response and dose-response after 
the human breast cancer irradiated with a range of 
laser parameters. 
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2.0  EXPERIMENTAL 
 
2.1  Chemicals and Cell Line 
 
MDA-MB-231, human breast cancer cells were a kind 
gift on Dr. Pauliena Bohari (Faculty of Biosciences and 
Medical Engineering, Universiti Teknologi Malaysia). 
Cells were grown in Dulbecco’s Modified Eagle’s 
Medium (DMEM), with 10% FBS, Fetal Bovine Serum and 
1% Penicillin-Streptomycin Liquid and kept at 37℃ in 
incubator with 5% CO2. The viability of the cells were 
measured with MTT assay, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide. 
 
2.2  In Vitro Treatment Protocol 
 
MDA-MB-231 cells were seeded in 24-well plate with 
6×104 seeding density and incubated for 24 hours.  
After 24 hours, the medium for all cells were changed 
with new medium to make sure all cell have enough 
food and not to die because of the insufficient 
supplement. After the medium were renewed, cells 
were treated by the lasers and incubated for another 
24 hours before the cell viability determined by the MTT 
assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3  Laser treatment 
 
The treatments have been performed with two 
different lasers. The Excimer laser, which available with 
average powers up to 35 W with KrF at 248 nm and 
Nd:YAG laser, which have power up to 500W at 1064 
nm and 532 nm. For Excimer laser, KrF at 248 nm, a 
single pulse with constant frequency 20 Hz was used 
and the energy was varied in range 1 to 6 mJ 
delivered to the cells. The laser pulses were manually 
started using external trigger. A pulse of Nd:YAG laser 
at both 1064 and 532 nm were varied in energy from 
200 to 1200 mJ. The three different wavelength lasers 
were set with constant energy but the number of 
pulses was increase from 1 to 6 pulses. 24 hours before 
treatment, cells were seeded in 24-wellplate with 
seeding density 6×104. For laser irradiation, the 24-
wellplates were placed on a stationary platform and 
the 4 treatments were carried out 24 hours away from 
each other and the experiment was repeated 3 times. 
The treated samples were compared with controls 
cancer cells maintained in the same conditions, 
without laser irradiation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 The viability (percentage of total cells) of human breast cancer cell, MDA-MB-231 after irradiated by (a)Excimer KrF 
248nm (b)Nd:YAG 532nm (c)Nd:YAG 1064nm lasers with different energy 
 
Figure 2 The viability (percentage of total cells) of human breast cancer cell, MDA-MB-231 after irradiated by (a)Excimer 
KrF 248nm (b)Nd:YAG 532nm (c)Nd:YAG 1064nm lasers with different number of pulse 
.  
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Figura 3 The morphology of the human breast cancer cell 
MDA-MB-231 (a)control without treatment (b)treated by 
Excimer KrF 238nm, (c) treated by Nd:YAG 532nm, and 
(d)treated by Nd:YAG 1064nm 
 
 
2.4  Cell Viability   
 
The viability of cell MDA-MB-231 were determine by 
MTT(3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium 
bromide) assay. Once the laser treatment were done, 
the medium of each well were change with new 
medium and 5mg/mL MTT was added and the all the 
MTT procedures were done in the dark as it very 
sensitive to light. The MDA-MB231 cells were incubated 
for 4 hours at 37℃.  After 4 hours, the absorbance of 
the cells were measured at 577 nm using micro plate 
reader. The percentage of total cells was calculated 
from the absorbance value and analyzed.  
 
 
3.0  RESULTS AND DISCUSSION 
 
This experiment investigates the effects of different 
laser wavelength commonly used in clinical practice 
of laser phototherapy on human breast cancer cell 
MDA-MB-231. In the clinical treatment setting, breast 
cancer patients usually receive multiple treatments 
with the same laser device. Therefore, we also 
investigated the effects of repeated exposures doses 
on the human breast cancer cell line. The usage of 
specific wavelength and dose of laser phototherapy 
resulted in either stimulation or inhibition to no changes 
in cell growth. 
 
3.1  The Effect of Laser Wavelength and Energy 
  
The effect of laser treatment on cell viability of breast 
cancer cell, MDA-MB-231 was analyzed. The result 
showed in Figure 1 (a) after being irradiated by 
Excimer 248 nm laser, the cell viability of MDA-MB-231 
increased up to 157%. However, the cell percentage 
was decrease as the laser energy was increased. This 
finding consistent with Zainudin et al. [24] which it was 
reported that the irradiation of F2 excimer laser 157 nm 
was improved the spreading, attachment and growth 
of human corneal limbal epithelial HLE cells. In other 
research, Olivia Serdarevic et al. [25] reported at the 
248-nm wavelength, the thermal effects of laser 
become more dominant therefore; all the fungal 
elements will be ablated. These ranges of laser 
wavelength are suitable for healing treatment acting 
as sterilization agent.  
The result in Figure 1 (b) & (c) shows after irradiate by 
both Nd:YAG at 1064nm and 532nm the percentage 
of total cell are lesser compare to the control 
untreated breast cancer cells. However, when the 
cells were treated by Nd:YAG with same energy 
200mJ but different wavelength, it shows that at 
wavelength 1064nm, there are more cell death which 
have only 74% of cell survived after the treatment 
compare to the cell treated by 532 nm which have 
84%. As the laser energy of both 532 and 1064 nm 
Nd:YAG laser were increased, the percentage of cell 
survive were decreased.  
Base on literature, there are records on therapeutic 
effects by low-level of laser in range of visible to near-
infrared wavelengths, 500 – 1000 nm. The therapeutic 
effects caused by laser phototherapy, such as 
increasing cellular activity not only influenced by the 
laser wavelength, doses of exposure, power density , 
as well as the laser frequency of treatment and type of 
injury and tissue condition of the breast cancer patient 
[26]. 
The mechanism of laser-tissue interaction was 
explained by Welch et al. [27]. In laser photothermal 
reactions, the laser light will absorb by cell 
chromophores and will convert to heat. This causes a 
rise in temperature of the cells and the heat will diffuse 
through the cell causing a rise in temperature in the 
surrounding cell. If the heat is high enough, it will result 
in denaturization, and even vaporization.  The 
damage done to the cell depends on the 
temperature that is reached.  
 
3.2  The Effect of Number of Laser Pulse on Cell Viability 
  
Although using different source of laser will increase 
and decrease the MDA-MB-231 cell viability, additional 
pulses of laser exposures had nearly no effect on the 
result as shown in Figure 2 (a) (b) and (c). When MDA-
MB-231 cells were treated with more than one 
exposure of laser irradiation at three different 
wavelengths, there were no significant changes on 
viability of the cells. This result proved the study 
conducted by Powell et al. as they reported that no 
change in proliferation of the breast cancer cell MCF-7 
when irradiated with more than one exposure doses of 
laser [28].  
The morphology of MDA-MB-231 after treatment was 
rounded compare to controlled breast cancer cell, 
which the morphology is epithelial. The spherical 
structure of cell was indicating the death cell as 
reported by a few studies on the morphology of death 
cell for MDA-MB-231 [29-31]. Figure 2 (a) (b) & (c) show 
there are more spherical shape in morphology of cell 
treated by 1064 nm laser, followed by 532 nm. The cell 
death is due to heat absorbed by cell chromophores 
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from the laser light. If the electric field is very high, a 
small region of plasma will occur with high electric 
fields, associate with dielectric breakdown, the 
formation of shockwave, and tissue rupture [29]. 
 
 
4.0  CONCLUSION 
 
Although these results does not show any significant 
laser-induced modification of cancer cell behaviour, 
further in vivo studies with high methodology quality 
are needed to better understand on the action 
mechanism of laser and improve the safely applying 
laser therapy to prevent and minimize the 
postmastectomy lymphedema. 
 
 
Acknowledgement 
 
We wish to thank to Gavornment of Malaysia through 
FRGS grant vote 4F543 and MyBrain 15 for the 
scholarship to the first author. We also thanks Faculty of 
Biosciences and Medical Engineering, Universiti 
Teknologi Malaysia (UTM) for providing facilities and 
services.  
  
 
References 
 
[1] Rubinov, A. N. 2003. Physical Grounds For Biological Effect 
Of Laserradiation. J. Physics D: Appl. Physics. 36: 2317-2330. 
[2] Hawkins, D. H., Tech, M. Abrahamse, H. 2006. The Role Of 
Laser Fluence In Cell Viability, Proliferation, And Membrane 
Integrity Of Wounded Human Skin Fibroblasts Following 
Helium-Neon Laser Irradiation. Laser Surg. Med. 38: 74-83. 
[3] Carati, C. J., Anderson, S. N., Gannon, B. J. and Piller, N.B. 
2003. Treatment Of Postmastectomy Lymphedema With 
Low-Level Laser Therapy: A Double Blind, Placebo-
Controlled Trial. Cancer. 98: 1114-1122. 
[4] Gur, A., Cosut, A., Sarac, A. J., Cevik, R., Nas, K. Uyar, A. 
2003. Efficacy Of Different Therapy Regimes Of Low-Power 
Laser In Painful Osteoarthritis Of The Knee: A Double-Blind 
And Randomized-Controlled Trial. Laser Surg. Med. 33: 330-
338. 
[5] Hopkins, J. T., McLoda, T. A., Seegmiller, J. G. and Baxter, G. 
D. 2004. Low-Level Laser Therapy Facilitates Superficial 
Wound Healing In Humans: A Triple-Blind, Sham-Controlled 
Study. J. Athl. Training. 39: 223-229. 
[6] Carati, C. J., Gannon, B. J. and Piller, N. B. 2004. Low-Level 
Laser As A Treatment Option For Postmastectomy 
Lymphedema. Am. J. Oncol. 3: 2-7. 
[7] Oliver, G. and Detmar, M. 2002. The Rediscovery Of The 
Lymphatic System: Old And New Insights Into The 
Development And Biological Function Of The Lymphatic 
Vasculature. Genes Dev. 16: 773-783. 
[8] Kaviani, A., Fateh, M., Nooraie, R. Y., Alinagi-Zadeh, M. 
Ataie-Fashtami, L. 2006. Low-Level Laser Therapy In 
Management Of Postmastectomy Lymphedema. Laser 
Med. Sci. 21: 90-94. 
[9] Hayes, S., Cornish, B. Newman, B. 2006. Prevalence And 
Cumulative Burden Of Lymphoedema Between 6 To 18 
Months Following Treatment For Breast Cancer In Brisbane 
Women. 6th Australasian Lymphology Association 
Conference. 106-110. 
[10] Casley-Smith, J. 1992. Modern Treatment Of Lymphoedema. 
I. Complex Physical Therapy: The First 200 Australian Limbs. 
Australasian Journal of Dermatology. 33(2): 61-8. 
[11] Harris, S. R., Hugi, M. R., Olivotto, I. A., Levine, M. 2001. 
Clinical Practice Guidelines For The Care And Treatment Of 
Breast Cancer: 11. Lymphedema. Canadian Medical 
Association Journal. 23: 164(2): 191-9.  
[12] Rodrick, J. R., Poage, E., Wanchai, A., Stewart, B. R., 
Cormier, J. N., Armer, J. M. 2013. Complementary, 
Alternative, And Other Non-Complete Decongestive 
Therapy (CDT) Treatment Methods In The Management Of 
Lymphedema. A Systematic Search And Review. American 
Academy of Physical Medicine and Rehabilitation. 6: 250-
274. 
[13] Carati, C. J., Anderson, S. N., Gannon, B. J., Piller, N. B. 2003. 
Treatment Of Postmastectomy Lymphedema With Low-
Level Laser Therapy. A Double Blind, Placebo-Controlled 
Trial. Cancer. 98(6): 1114-1122. 
[14] Ahmed Omar, M. T., Abd-El-GayedEbid, A., El Morsy, A.M. 
2011. Treatment Of Postmastectomy Lymphedema With 
Laser Therapy: Double Blind Placebo Control Randomized 
Study, Journal of Surgical Research. 165: 82-90. 
[15] Kozanoglu, E., Basaran, S., Paydas, S., Sarpel, T. 2009. 
Efficacy Of Pneumatic Compression And Low-Level Laser 
Therapy In The Treatment Of 
Postmastectomylymphoedema: A Randomized Controlled 
Trial. Clinical Rehabilitation. 23(2): 117-124. 
[16] Zainuddina, Traian, V., Chirilaa, Zeke Barnarda, Gregory S., 
Watsonf, ChiongTohc, IdrissBlakeyc, Andrew K. Whittakera, 
David J. T., Hill. 2011. F2 Excimer Laser (157 nm) Radiation 
Modification And Surface Ablation Of PHEMA Hydrogels 
And The Effects On Bioactivity: Surface Attachment And 
Proliferation Of Human Corneal Epithelial Cells Radiation. 
Physics and Chemistry. 80(2): 219-229 
[17] Richard W. Darrell, Ronald R. Krueger, Stephen L. Trokel. 
1985. Excimer Laser Therapy for Experimental Candida 
Keratitis Olivia Serdarevic. American Journal of 
Ophthalmology. 99(5): 534-538 
[18] Powell, K., Low, P., McDonnell, P. A., Laakso, E. L., Ralph, S. J. 
2010. The Effect Of Laser Irradiation On Proliferation Of 
Human Breast Carcinoma, Melanoma, And Immortalized 
Mammary Epithelial Cells. Photomedicine And Laser 
Surgery. 28(1): 115-123. 
[19] Schartinger, V. H., Galvan, O., Riechelmann, H., Dudás, J. 
2012. Differential Responses Of Fibroblasts, Non- Neoplastic 
Epithelial Cells, And Oral Carcinoma Cells To Low Level 
Laser Therapy.  Support Care Cancer. 20(3): 523-529. 
[20] Gao, X., Chen, T., Xing, D., Wang, F., Pei, Y., Wei, X. 2006. 
Single Cell Analysis Of PKC Activation During Proliferation 
And Apoptosis Induced By Laser Irradiation. Journal of 
Cellular Physiology. 206(2): 441-448.  
[21] Mikhailov, V. A., Denisov, I. N., Frank, G. A. and Voltchenko, 
N. N. 2000. Results Of Treatment Of Patients With Second- To 
Third-Stage Breast Cancer By Combination Of Low-Level 
Laser Therapy (LLLT) And Surgery: Ten-Year Experience. 
Proc. Soc. Photo. Opt. Instrum. Eng. 4166: 40. 
[22] Lenhard, R. E., Osteen, R. T., and Gansler, T. 2001. Clinical 
Oncology. Atlanta GA. The American Cancer Society. 25-
30. 
[23] Werneck, C. E., Pinheiro, A. L. B., Pacheco, M. T. T., Soares, 
C. P., and De Castro, J. L. F. 2005. Laser Light Is Capable Of 
Inducing Proliferation Of Carcinoma Cells In Culture: A 
Spectroscopic In Vitro Study. Photomedicine and Laser 
Surgery. 23: 300-303. 
[24] Halsted W. 1894. The Results Of Operations For The Cure Of 
Cancer Of The Breast Performed At The Johns Hopkins 
Hospital From June, 1889 To January, 1894. Ann Surg. 20(5): 
497-555. 
[25] Silvia, E. M., Lilian, V. R., Mônica F. F., Angélica, R. A., 
Camila, T. V. 2014. Treatment Of Upper Limb Lymphedema 
With Low-Level Laser: A Systematic Review. 
FisioterapiaemMovimento. 27(4): 663-74 
[26] Karu T. I .1987. Photobiological Fundamentals Of Low-Power 
Laser Therapy. IEEE J Quantum Electron. 23(10): 1703-17. 
[27] Welch, Jorge, A. J., Torres, H., Wai-Fung Cheong. (1989). 
Laser Physics and Laser-Tissue Interaction. Texas Heart 
Institute Journal. 16(14): 1-9. 
320                           Aishah, Noriah & Siti Pauliena / Jurnal Teknologi (Sciences & Engineering) 78:3 (2016) 315–320 
 
 
[28] Harris, S. R., Hugi, M. R., Olivotto, I. A. Levine, M. 2001. 
Clinical Practice Guidelines For The Care And Treatment Of 
Breast Cancer: 11. Lymphedema. Can. Med. Assoc. J. 164: 
191-199. 
[29] Mgbonyebi, O. P., Russo, J., Russo, I. H. 1999. Roscovitine 
Induces Cell Death And Morphological Changes Indicative 
Of Apoptosis In MDA-MB-231 Breast Cancer Cells. Cancer 
Research. 59(8): 1903-10. 
[30] Serge, H., Yves, L., Marc, P. 2000. Oleate Activates 
Phosphatidylinositol 3-Kinase and Promotes Proliferation and 
Reduces Apoptosis of MDA-MB-231 Breast Cancer Cells, 
Whereas Palmitate Has Opposite Effects.  Cancer Research. 
60: 6353– 6358.  
[31] Keiko, T., George, L. 2004. Disruption Of Mitochondria During 
Tocotrienol-Induced Apoptosis In MDA-MB-231 Human 
Breast Cancer Cells. Biochemical Pharmacology. 67: 315-
324. 
 
 
